Back to results
US 2003/0228622 A1Published application
Lanthanide binding tags
AssigneesMassachusetts Institute of Technology, Trustees of Boston University
InventorsBarbara Imperiali, Karen N. Allen, Katherine J. Franz
Life of this patent
Estimating the term…
Abstract
The present invention provides lanthanide binding tags (LBT) that selectively complex trivalent lanthanide (Ln) ions and afford stable complexes with desirable physical properties, including at least one of fluorescence and anomalous x-ray scattering.
Claims22
A method of determining the structure of a peptide, comprising:
- a) expressing a fusion peptide comprising the peptide and a lanthanide binding tag;
- b) isolating said fusion peptide;
- and
- c) forming a crystal of said fusion peptide in the presence of a lanthanide ion;
- wherein the lanthanide binding tag is a peptide that contains:
- (a) about 12 to about 30 amino acid residues, (b) at least two carboxylic groups and (c) at least one oxygen containing group selected from the group consisting of an backbone carbonyl group, the carboxyl terminus, Ser, Thr, Gln, Asn, or an oxygen of a bound solvent molecule and
- wherein the lanthanide binding tag binds a lanthanide ion with an affinity (KD) of about 1 nM to about 10 μM.
4 more elements
A method of detecting a peptide comprising:
- a) contacting a sample containing a fusion peptide comprising the peptide and a lanthanide binding tag with a lanthanide ion;
- b) determining the fluorescence of the sample;
- wherein the lanthanide binding tag is a peptide that contains:
- (a) about 12 to about 30 amino acid residues, (b) at least two carboxylic groups, (c) a fluorophore, and (d) at least one oxygen containing group selected from the group consisting of an backbone carbonyl group, the carboxyl terminus, Ser, Thr, Gln, Asn, or an oxygen of a bound solvent molecule and
- wherein the lanthanide binding tag binds a lanthanide ion with an affinity (KD) of about 1 nM to about 10 μM.
2 more elements
A method of imaging, comprising:
- a) injecting a solution containing a complex of a lanthanide ion and a fusion peptide comprising a peptide and a lanthanide binding tag into a patient;
- b) performing imaging on said patient;
- wherein the lanthanide binding tag is a peptide that contains:
- (a) about 12 to about 30 amino acid residues, (b) at least two carboxylic groups and (c) at least one oxygen containing group selected from the group consisting of an backbone carbonyl group, the carboxyl terminus, Ser, Thr, Gln, Asn, or an oxygen of a bound solvent molecule and
- wherein the lanthanide binding tag binds the lanthanide ion with an affinity (KD) of about 1 nM to about 10 μM.
2 more elements
A lanthanide binding peptide comprising an amino acid sequence:
- T0-X1-X2-X3-X4-X5-Gly6-Trp7-X8-XH-Glu9-X10-X11-Glu12-Leu 13-T14
- where T0 and T14 are each independently absent, an amino acid or peptide;
- X1 is Asp, Asn, Ser, or Glu,
- X2 is Trp, Tyr, Phe, Gln, Ile or Lys,
- X3 is Asp, Asn, Ser, or Glu,
- X4 is Trp, Tyr, Ala, Gln, Ile or Lys,
- X5 is Asp, Asn, Ser, or Glu,
- X8 is Trp, Tyr, Phe, Gln, Ile, Lys or Arg,
- XH is absent or is a glycine,
- X10 is Trp, Tyr, Glu, Asp, Lys or Phe, and
- X11 is Trp, Tyr, Glu, Asp, Lys or Leu;
- wherein the peptide contains 14-30 amino acid residues.
- The lanthanide-binding peptide of claim 16, wherein T0 and T14 each are independently a peptide containing a cysteine residue.
10 more elements
A complex comprising the fusion protein of claim 18 and a lanthanide ion.
Dependencies are inferred from the claim text.